Drug intelligence / Profile preview

perinatal tissue mesenchymal stem cells

Development stage: Phase 2
Lead developer: Foshan Maternity & Child Healthcare Hospital
Modality: Hydrogel Systems → Drug Delivery Systems, Stem Cell Therapies → Cell Therapies
Administration: Transdermal, Topical

Overview

An investigational cell therapy consisting of umbilical cord-derived mesenchymal stem cells (UC-MSCs) formulated in a transdermal hydrogel. Developed by the Maternal and Child Health Hospital of Foshan (Southern Medical University Affiliated Maternal & Child Health Hospital of Foshan), this therapy is designed to treat and improve the appearance of cesarean section scars (cicatrix). The mesenchymal stem cells are believed to exert therapeutic effects through their regenerative properties, promoting wound healing and scar tissue remodeling via paracrine signaling and direct cellular interaction. The therapy is currently being evaluated in a Phase II randomized, double-blind, placebo-controlled study (NCT02772289) to assess its long-term efficacy in primiparous women using the Vancouver Scar Scale.

Other names: umbilical cord mesenchymal stem cellsUC-MSCsperinatal tissue-derived mesenchymal stem cellsMesenchyme Stem Cells-Maternal and Child Health Hospital of Foshan-cicatrixPerinatal Tissue Mesenchyme Stem Cells

Beyond the preview

Go deeper on perinatal tissue mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on perinatal tissue mesenchymal stem cells.

Explore the full profile